Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technipro-Pulmomed is a Swiss medical technology company that specializes in respiratory therapy and sleep medicine. Founded in 1998 and headquartered in Altendorf, the company provides a wide array of diagnostic and therapeutic devices, including nebulizers, oxygen concentrators, and CPAP machines. They serve both clinical environments and homecare settings, focusing on patients with chronic respiratory diseases such as COPD, asthma, and cystic fibrosis. In 2018, the company was acquired by PanGas AG, a subsidiary of the Linde Group, to strengthen its position in the Swiss healthcare market. Technipro-Pulmomed is recognized for its technical expertise, maintenance services, and comprehensive support for respiratory patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technipro-Pulmomed.